Introduction
============

Small Ruminant Lentivirus (SRLV) infection is spreading all over the world, with new descriptions in countries such as Poland \[[@B1]\], Sultanate of Oman, Canada \[[@B2]\], Slovenia \[[@B3]\], Russia \[[@B4]\] and new genotypes such as A12, A14 and A15 \[[@B3]\], E and B3 \[[@B5]-[@B7]\]. Today, highly efficient prophylactic/therapeutic measures against SRLV do not exist, and control is frequently based on early diagnosis and culling of seropositive ewes and their progeny. SRLV infection occurs early after parturition by the lactogenic route or direct contact with infected animals. The main target cells for the virus in vivo are the monocyte/macrophage lineage \[[@B8]\] whereas CD4 T cells and dendritic cells also play important roles \[[@B9],[@B10]\]. Upon infection, initial viral replication triggers T cell and antibody responses that control virus burst and allow serological diagnosis. Following this stage, viral infection is partially controlled but provirus is already integrated at low levels into the cellular genome mainly of monocytes, myeloid cells or tissue macrophages \[[@B11]\]. The provirus remains latently integrated until viral proteins are produced and new virions are released. This results in a continuous process of low viral replication together with expression of pro-inflammatory cytokines and chemokines that often lead to a strong inflammatory process, tissue damage and disease development \[[@B11]\]. The permissiveness of macrophages to SRLV in vitro is modulated by cytokines. Specifically, IFN-γ restricts SRLV replication by delaying macrophage maturation \[[@B12]-[@B14]\], whereas increased IL-8, GM-CSF, IL-16, IL-1beta, IL-4 and IL-10 have been associated in vivo to seropositivity \[[@B15]-[@B18]\] and SRLV replication in vitro.

Cells of the monocyte-macrophage lineage are heterogeneous reflecting the plasticity and versatility of the response to environmental stimuli required for effective immune responses. Different patterns of macrophage maturation have been identified in humans and mice according to differentiation mechanisms and identification of markers for such subpopulations \[[@B19]\]. Macrophage classical (M1 phenotype) and alternative activations (M2 phenotype) depend on the presence of molecules secreted by T-helper CD4 or NK cells \[[@B20]\]. In particular, M1 phenotype is induced by Th1-signature cytokines such as IFN-γ and TNF-α as well as LPS, resulting in enhanced microbicidal ability in addition to increased proinflammatory responses and cellular immunity \[[@B21]\]. In HIV-1 infection, the M1 profile is characterized by down-regulation of CD4 receptors, increased CCR5-binding chemokines and significantly decreased viral production, likely at pre-integration steps \[[@B22]\]. On the contrary, the M2 phenotype is displayed after induction with Th2-hallmark cytokines such as IL-4 and IL-13, which play a major role in responses against parasites, allergy, wound healing, tissue remodeling or in some cases to regulate the immune response \[[@B23]\].

In contrast with humans and mice, data on macrophage polarization and its effect on lentiviral infection are lacking in other animal species. This study aimed to investigate whether sheep and goats, both targets to SRLV infections, also display macrophage subpopulations. For this, we explored putative stimuli that would elicit such subpopulations and determined cell markers to identify them. With the information obtained, we investigated if the putative subpopulations had different permissiveness and effectiveness of infection by different strains of SRLV, according to performance in an entry assay and retrotranscriptase activity, respectively.

Materials and methods
=====================

Cells and viruses
-----------------

Fibroblastic-like cells from skin biopsies were obtained from SRLV-free animals. Cells were grown in DMEM medium supplemented with 10% foetal bovine serum, 2% L-glutamine, 1% antibiotics/antimycotics mix and 1:1000 gentamicin (Sigma-Aldrich, Steinheim, Germany).

Blood monocyte-derived macrophages (MDM) were obtained by isolation of peripheral blood mononuclear cells (PBMC) from SRLV-free sheep and goats in compliance with the relevant National legislation on experimental animals and animal welfare, upon authorization by the competent authority (Italian Ministry of Health-Directorate General Animal Health-Office VI, permit no.07/2009B), by Ficoll (1.077) gradient centrifugation. MDM were grown in RPMI complete medium, containing RPMI 1640 supplemented with 10% foetal goat serum, 10 mM sodium pyruvate, 1% non-essential amino acids, 1% vitamins, 1% antibiotics/antimycotics mix and 1:1000 gentamicin, 1% L-glutamine and 50 μM 2-mercaptoetanol (Sigma-Aldrich).

HEK293-T cells were cultured in DMEM (GIBCO, Invitrogen, Paisley, UK) supplemented with 10% foetal bovine serum, 1% antibiotics/antimycotics and 1:1000 gentamicin.

CHO cells and CHO-MR cells expressing mouse mannose receptor (kindly provided by Dr Luisa Martínez-Pomares; \[[@B24]\]) were cultured in F12 nutrient mixture with 10% foetal bovine serum, 1% L-glutamine, 1% antibiotics/antimycotics and 1:1000 gentamicin.

Six different SRLV strains were used, one from the genotype A VMV-like Ev1 strain \[[@B25]\], three of them belonging to the genotype B CAEV-Co \[[@B26]\] and CAEV-To1/89 (B1, \[[@B27]\]), and 496 (B2, \[[@B28]\]) and two belonging to the genotype E, Roccaverano (E1, \[[@B5]\] and Seui (E2, \[[@B6]\]).

Cytokine expression
-------------------

Different small ruminant cytokines were used as well as LPS (Sigma) as stimulators for macrophage polarization. Plasmid pN3-IFN-γ containing the ovine IFN-γ gene was kindly provided by Dr Marie Suzan-Monti (Faculté de Médecine, Marseille, France).

Primer design for caprine IL-4, IL-13 and IL-10 cloning (Table [1](#T1){ref-type="table"}) was based on sequences available at Genbank (accession numbers U34273.1, NM_001082594 and U11421, respectively). Primers contained specific restriction sites (*XhoI* and *Acc651*) for posterior subcloning into the pN3 eukaryotic expression vector. pN3 is derived from pN3-EGFP (Clontech Laboratories, Saint-Germain-en-Laye, France) from which the EGFP gene was removed \[[@B29]\]. All the forward primers contained the Kozak consensus sequence ACC. ATG.G.

###### 

Primers used for amplification and cloning of the cytokines and the Caev-Cork env gene used in entry assays.

  **Molecule**      **Primer**                                    **Probe**                                  **Amplicon length**                       
  ----------------- --------------------------------------------- ------------------------------------------ ----------------------------------------- -------------------
  IL-4              AATT[CTCGAG]{.ul}**ACCATGG**GTCTCACCTCCCAGC   AATTT[GGTACC]{.ul}TCAACACTTTGAGTATTTCTCC                                             472 nt
  IL-13             AATT[CTCGAG]{.ul}**ACCATGG**CGCTCTTCTTGAC     ATTT[GGTACC]{.ul}TCAGTTGTAACTTCCATTGCG                                               556 nt
  IL-10             AATT[CTCGAG]{.ul}**ACCATG**CCCAGCAGCTCAG      ATTT[GGTACC]{.ul}TTACATCTTCGTTGTCATGTA                                               419 nt
  CAEV-Cork *env*   ATAT[AGATCT]{.ul}CCACCATG                     ATTT[GCGGCCGC]{.ul}TATTAGTCCTCTTTAG                                                  2834 nt
  TNF-α qPCR        GGTGCCTCAGCCTCTTCTC                           GAACCAGAGGCCTGTTGAAG                       6-FAM-TGGTTGCAGGAGCCACCACG-TAMRA          134 nt
  CD80 qPCR         CTGTGATTACAACACGACCACTGA                      ATGGTGCGGTTCTCGTATTCA                      6-FAM-AACTGGCAAGCCTTCGGATCTACTGGC-TAMRA   128 nt \[[@B30]\]
  A3Z1 qPCR         TCCGTTCTTGGAATCTGGAC                          GTATAGATGCGGGAGGCAAA                                                                 151 nt
  MR qPCR           TGGCAAATCCAGTTGTTAAGATGTT                     AGAATGTTGAATACTGTGGCGAGTT                                                            91 nt \[[@B31]\]
  DC-SIGN qPCR      GGTTCCGGAGTCTGACTGAAGTT                       GGTCAGGCGCTGTAGGATCTC                                                                73 nt
  IL-10 qPCR        CGGCGCTGTCATCGTTTT                            TCTTGGAGCATATTGAAGACTCTCTTC                6-FAM-CCTGCTCCACCGCCTTGCTCTTG-TAMRA       82 nt

Sequences are listed 5′to 3′; restriction enzyme recognition sites are underlined; Kozak sequences are in bold. A3Z1, MR and DC-SIGN were amplified using SybrGreen Master Mix (Takara).

Primers and probes (when corresponding) for relative expression quantification using real time PCR (qPCR) are also indicated.

Polymerase chain reactions (PCR) were performed in a final volume of 50 μL with 3 μL of the cDNA samples. The reaction mixture contained 1× PCR buffer, 2 μM dNTP, 3 nM of each primer and 1.25 units of Hot Start Polymerase (Qiagen, Hilden, Germany). The PCR started with a 95 °C step (15 min), followed by a denaturation step at 94 °C for 30 s, 1 min of annealing at 55 °C and a 1 min extension at 72 °C. A final extension of 72 °C for 10 min was also carried out.

PCR products were submitted to electrophoresis in a 1.5% agarose gel, and the selected amplicons were purified by Qiagen PCR clean-up kit, digested with *XhoI/Acc561* restriction enzymes and cloned into the previously digested expression vector pN3. Chemically TOP10 competent cells (Invitrogen, Paisley, UK) were transformed and grown overnight in LB agar plates supplemented with kanamycin (50 ng/mL). Colonies were screened by PCR with specific primers for the vector sequences, run in 1.5% agarose gel and positive clones were selected and sequenced (Secugen, Madrid, Spain).

Plasmids containing the correct IL-4, IL-13 or IL-10 sequence were employed for transfection of cultured HEK 293-T cells using the Amaxa Nucleofector II device and following the manufacturer's protocol from Cell Line Nucleofector Kit V (LONZA, Köln, Germany). After 72 h, cell supernatants were collected, clarified by centrifugation and frozen at −80 °C. HEK 293-T cells were also transfected with the empty plasmid pN3 and the supernatant was used as a non-stimulated control.

Quantification of cytokines for use as stimulators in macrophage polarization
-----------------------------------------------------------------------------

IFN-γ and IL-4 cytokine concentrations and biological activities in HEK 293-T culture supernatants was measured with the Ovine IFN-γ ELISA kit (Mabtech, Nacka Strand, Sweden) and the Bovine IL-4 screening set (Thermo Scientific, Rockford, USA), respectively, according to the manufacturers' protocols. The concentration obtained was similar in both cases, ranging from 600 to 2600 ng and was adjusted to 50 ng/mL for use in MDM stimulations (see below).

In the absence of commercially available quantification kits for small ruminant IL-10 and IL-13, the concentration range of these cytokines in the HEK 293-T culture system was assumed to be the same as for IFN-γ and IL-4. Nevertheless, biological activity was first verified by addition of 5, 10 and 20-fold dilutions of the HEK 293-T culture supernatants to MDM, followed by a 4 h incubation, cell harvesting, RNA extraction and determination of marker expression by real time RT-PCR (see below).

Macrophage polarization
-----------------------

LPS and cytokines (IFN-γ, IL-4, IL-13 and IL-10) were added to macrophages on day 3 of culture, at a final concentration of 50 ng/mL. Supernatants from HEK 293-T cultures transfected with empty pN3 plasmid were used as the negative control. Fresh medium supplemented with cytokines was partially replaced after 3--4 days of culture. On day 6, stimulated MDM were either collected for RNA extraction and marker molecule expression analysis (at least six independent wells for each treatment), or infected for RT activity measurements or used in entry assay experiments, as indicated below.

Marker expression analysis by real time RT-PCR
----------------------------------------------

RNA was extracted from cytokine treated and pN3-treated MDM and real time RT-PCR were carried out using specific primers and probes according to the differentiation pathway, TNF-α, CD80 and APOBEC3Z1 (A3Z1) for M1 phenotype and Mannose Receptor (MR), DC-SIGN and IL-10 for M2 phenotype (Table [1](#T1){ref-type="table"}). TNF-α, CD80 and IL-10 real time PCR procedures were performed using specific probes and conditions described previously for CD80 \[[@B30]\] A3Z1, MR and DC-SIGN expression was assessed with specific primers and SybrGreen Master Mix (Takara, Otsu, Japan) following conditions described previously \[[@B31]\].

β-actin expression was measured as a housekeeping gene, thus β-actin Ct values were subtracted from the markers' Ct values for each sample, in order to obtain the 2^-ΔCt^ values used for comparisons.

Viral infections and RT activity determination
----------------------------------------------

Six-day stimulated MDM were infected at 0.1 TCID~50~/cell with one of the six SRLV strains under study, being one of genotype A (Ev1), three of genotype B (CAEV-Co, CAEV-To and 496) and two of the recently described genotype E of SRLV (Roccaverano and Seui). Following 2-h incubation, the cells were washed three times with PBS and fresh medium containing the stimulating cytokines was added. Supernatants were collected at 7 days post inoculation for Retrotranscriptase activity (RT activity) quantification, performed with the HS-Lenti RT activity kit (Cavidi, Uppsala, Sweden) according to the manufacturer's instructions.

Viral pseudotype constructions and entry assay
----------------------------------------------

Plasmids containing the envelope gene (*env*) of Roccaverano, Seui \[[@B32]\] and Ev1 strains \[[@B33]\] were used. In addition, CAEV-Co *env* was cloned into the pCMV plasmid \[[@B34]\] using the same strategy and with the primer pairs shown in Table [1](#T1){ref-type="table"}. Positive clones were screened by restriction enzyme digestion, sequencing and by assessing the formation of syncitya in cultured skin fibroblasts. pMDG plasmid encoding for vesicular stomatitis virus env glycoprotein (VSV-G) was used as a positive control (kindly provided by Prof. Greg J. Towers, University of London, UK).

For entry assays, pseudotyped virions were produced by co-transfection of HEK 293-T cells with two types of plasmids as described \[[@B32]\]. Briefly, pCAEV-AP (encoding alkaline phosphatase), kindly provided by Dr Isidro Hötzel, \[[@B35]\]; and one of the *env*-containing plasmid constructs described above. HEK 293-T cell culture supernatants containing the pseudotyped viruses were collected after 48 h, clarified and used in 10-fold dilutions to infect MDM, CHO and CHO-MR cells. After 48 h, the cells were stained using the alkaline phosphate substrate BCIP/NBT (Thermo Scientific) \[[@B36]\] and the results were expressed as focus-forming unit per mL (FFU/mL).

Mannan treatment
----------------

Stimulated and pN3-stimulated MDM, CHO and CHO-MR cells were treated with 1 mg/mL of mannan (Sigma-Aldrich), for 30 min at 37 °C and 5% CO~2~, and infected with 10-fold dilutions of the pseudotyped viruses plus mannan following the entry assay procedure described above. Cells non-treated with mannan were included as controls.

Virus-induced polarization
--------------------------

MDM were allowed to differentiate in complete medium without cytokine stimulation and then infected with 0.1 TCID~50~/mL of the six strains mentioned above (EV1, CAEV-Co, CAEV-To, 496, Roccaverano and Seui). On day 7 of infection, the cells were harvested and RNA were extracted and retrotranscribed to cDNA. Real time PCR for the detection of TNF-α, CD80, A3Z1, MR, DC-SIGN and IL-10, were carried out as described above.

Macrophage versatility
----------------------

MDM were obtained and allowed to differentiate into M1 or M2 profiles with IFN-γ and IL-4 respectively through two cycles of stimulation (3 days each). After the second, MDM were washed and stimulated for 3 additional days with a cytokine of the opposite phenotype (M1 vs. M2), then RNA was obtained and cDNA were subjected to specific amplification of differentiation pathway markers.

Statistical analysis
--------------------

The effects of different stimulators on marker expression were tested evaluating correlation between 2^-ΔCt^ and stimulator concentration with the Spearman's rank correlation test. In order to evaluate the possible differences in expression among cells treated with different stimuli or non-treated (i.e. control pN3 group), data were analysed using Kruskal Wallis test. If a significant difference was recorded, a planned comparison between each treated cell group and the control was performed using 2-tailed Wilcoxon rank-sum test or Mann-Whitney's test. Correlations and differences were considered significant if associated *p* \< 0.05.

Results
=======

Cytokine biological activity
----------------------------

Supernatants of HEK-293-T cells transfected with IL-13 or IL-10 expression plasmids were found to affect MDM M1/M2 marker expression (quantified by real-time RT-PCR). Variation of M1/M2 markers was dose dependent (Figure [1](#F1){ref-type="fig"}). IL-13 favored MR expression since higher dilutions showed lower MR expression levels (Spearman Rho = 0.956, *p* \< 0.005); similarly, TNF-α expression slightly increased with higher dilutions of IL-13 (Spearman Rho *p* \< 0.005), but resulted in negligible variations. Even if the relationship is not linear, IL-10 showed as did IL-13 a positive relation with MR since the more cytokine is present the higher level of MR expression is observed.

![**Biological activity.** Supernatants containing caprine IFN-γ **(a)**, IL-4 **(b)**, IL-13 **(c)** and IL-10 **(d)** produced in HEK293-T cells, as described in Material and Methods were applied to MDM in serial dilutions (1/5, 1/10 and 1/20). Biological activity was evaluated as the relative expression of TNF-α, MR and IL-10 evaluated by real time RT-PCR. Values are expressed as 2^-ΔCt^ × 100 normalized to β-actin.](1297-9716-44-83-1){#F1}

Therefore these cytokines, in addition to those whose activity had been assessed by commercial kits (IFN-γ and IL-4), were considered biologically active and suitable for further MDM stimulation studies.

Characterization and plasticity of polarized macrophages
--------------------------------------------------------

Phenotypic differences regarding cell morphology (shape and size) were clearly observed between differentially stimulated MDM after 3 days of cytokine stimulation. Specifically, IFN-γ and LPS-treated (Th1 cytokines) cells were small and round, whereas IL-4 treated MDM showed a dendritic-like shape with large pseudopodia. Finally, in macrophages exposed to IL-13, IL-10 and pN3 there appeared to be a mixture of morphological phenotypes.

Phenotypic characterization was further evaluated after two rounds (3 days each) of exposure to LPS, IFN-γ, IL-4, IL-13 and IL-10, by assessing the expression of TNF-α, CD80 and A3Z1 (M1 phenotype) and MR, DC-SIGN and IL-10 (M2 phenotype) markers. Relative marker expression, measured by real time RT-PCR (Figure [2](#F2){ref-type="fig"}) indicated that, as described in other species, TNF-α expression increased in IFN-γ stimulated MDM from caprine and ovine origin and therefore this molecule could be a good marker for M1 polarization. In contrast, MR expression increased in IL-4 stimulated MDM and thus could be considered as a good marker for M2 polarization.

![**Relative marker expression in stimulated MDM.** MDM were cultured in the presence of the particular cytokine or control (pN3). Relative expression of TNF-α **(a)**, CD80 **(b)**, A3Z1 **(c)**, MR **(d)**, DC-SIGN **(e)** and IL-10 **(f)** was measured by quantitative RT-PCR. The values are expressed as 2^-ΔCt^ × 100 median value (± interquartile range) of at least 3 independent experiments normalized to β-actin.](1297-9716-44-83-2){#F2}

Additional molecules evaluated in this study were identified as new markers for M1 or M2 macrophage populations. A3Z1 and CD80 were induced in IFN-γ stimulated MDM, identifying M1 macrophages. Conversely, DC-SIGN was highly expressed in IL-4 and IL-13 stimulated macrophages, identifying M2 macrophages (Figure [2](#F2){ref-type="fig"}).

IL-10 expression values did not seem to distinguish between different populations (p \> 0.05 in all comparisons), although expression was mainly observed in IL-4, IL-10 and LPS stimulated macrophages.

Apart from these clear patterns of M1 vs. M2 polarization, "single-effect" patterns associated to caprine or ovine species were also identified. Specifically, LPS stimulation resulted in highly increased levels of MR in goats and IL-10 in sheep and not in increased M1 cytokines, whereas IL-13 induced high levels of MR and DC-SIGN in both species. CD80 was a good marker for M1 macrophages in the caprine species whereas IL-4 stimulation led to expression of IL-10 only in sheep.

pN3 induced the lowest levels of stimulation in ovine and caprine macrophages. As in other animal models, pN3 (control) exposure resulted in increased levels of M2 marker expression.

In order to explore whether M1 and M2 were irreversibly differentiated cells, ovine macrophages were polarized into M1 and M2 patterns by stimulation with IFN-γ and IL-4 respectively, and then stimulated with a cytokine of the opposite pattern (IL-4 and IFN-γ, respectively). When M1 (IFN-γ stimulated) macrophages expressing high levels of TNF-α and A3Z1 markers were stimulated with IL-4, expression of these markers was significantly reduced (paired Wilcoxon Rank Sum test *p* \< 0.05 in both cases) while MR and DC-SIGN expression was increased (*p* \< 0.05 in both cases, Figure [3](#F3){ref-type="fig"}). Similarly, when M2 (IL-4 stimulated) macrophages were stimulated with IFN-γ, their profile changed drastically towards phenotype M1 with increased expression of TNFα and A3Z1 (*p* \< 0.05 in both cases) and significant reduction of MR expression (*p* \< 0.05). DC-SIGN only showed a trend to lower expression (*p* = 0.1). These results indicate that the polarization profile of small ruminant MDM is plastic and M1 and M2 patterns defined here can be reverted from one to the other according to cytokine availability.

![**Macrophage plasticity.** MDM were stimulated for a total of 9 days, 6 days with IFN-γ, IL-4 or pN3 (non-stimulated control) followed by a 3-day stimulation with the opposite cytokine as indicated with arrows. Relative expression of the markers TNF-α **(a)**, CD80 **(b)**, A3Z1 **(c)**, MR **(d)**, DC-SIGN **(e)**, and IL-10 **(f)** was quantified by real time RT-PCR after 6 days of total stimulation. The values are expressed as the median (± interquartile range) 2^-ΔCt^ × 100 value related to β-actin, and represent at least 3 independent experiments. \**p* \< 0.05 (paired Wilcoxon Rank Sum test).](1297-9716-44-83-3){#F3}

Susceptibility of MDM stimulated with cytokines to virus infection
------------------------------------------------------------------

Firstly, the MDM-SRLV combinations permissive to SRLV infection were chosen for infection after cytokine exposure. Combinations were designed including ovine macrophages and viral strains originally isolated from sheep, Ev1 (genotype A) or 496 (genotype B), and caprine macrophages and viral strains originally obtained from goats (CAEV-Co, CAEV-To, genotype B) or Roccaverano and Seui (genotype E). The corresponding MDM were submitted to two consecutive 3-day rounds of stimulation with cytokines, and then infected with different SRLV strains for 7 days to finally determine RT activity (Figure [4](#F4){ref-type="fig"}). The results indicate that M2 stimulated MDM when exposed to SRLV clearly favored viral replication. In contrast, M1 IFN-γ stimulated cells showed a reduced RT activity upon SRLV infection compared to cells exposed to pN3 or IL-4 (Wilcoxon Rank Sum test *p* \< 0.05; Figure [4](#F4){ref-type="fig"}). pN3 stimulated cells showed high levels of viral replication compatible with an M2 phenotype as shown in Figure [3](#F3){ref-type="fig"}. Thus, the ability to support SRLV replication (pattern of RT activity) differed according to the stimulatory cytokine, with IFN-γ (M1 phenotype) efficiently inhibiting infection independently of the strain or the ruminant species from which MDM were isolated.

![**SRLV replication in polarized macrophages.** MDM were exposed for 6 days to the cytokines IFN-γ, IL-4, or pN3 (non-stimulated control), and subsequently infected with different SRLV strains: EV1 (empty bars), 496 (full bars), CAEV-Cork (grey bars) CAEV-To (light grey bars), Roccaverano (horizontal-lined bars) and Seui (vertical-lined bars). RT activity was measured (A~450nm~) in clarified supernatants at 7 days post infection. The values are the median (± interquartile range) of at least 3 independent experiments. \* *p* \< 0.05 (paired Wilcoxon Rank Sum test).](1297-9716-44-83-4){#F4}

SRLV infection promotes the M2 differentiation pathway
------------------------------------------------------

Knowing that different cytokines trigger the establishment of different polarization patterns in small ruminant macrophages, we explored the hypothesis that SRLV would also induce a particular polarization pattern. For this and in the absence of cytokine stimulation, MDM were infected with different SRLV strains and differentiation markers quantified on day 7 of infection. All the SRLV strains used in this study induced upregulation of M2 phenotype markers, with increased MR and DC-SIGN expression values compared to those of pN3 treated (Figure [5](#F5){ref-type="fig"}). M2 pattern of differentiation was more evident when comparing M1 vs M2 markers since pN3 stimulation alone induced an M2 polarization (Figure [2](#F2){ref-type="fig"}). While M1 markers were induced to a maximum of 2-fold compared with the housekeeping gene, M2 marker induction was up to 75-times higher than that of β-actin (Figure [5](#F5){ref-type="fig"}).

![**Virus-induced polarization of MDM.** MDM were allowed to differentiate in the absence of cytokine and then infected with different SRLV strains (EV1, 496, CAEV-Cork, CAEV-To, Roccaverano and Seui) at a MOI of 0.1. Six day post-infection relative expression of the markers TNF-α **(a)**, CD80 **(b)**, A3Z1 **(c)**, MR **(d)**, DC-SIGN **(e)**, and IL-10 **(f)** was measured by quantitative RT-PCR. The values are expressed as 2^-ΔCt^ × 100, related to β-actin, and represent the median (± interquartile range) of at least 3 independent experiments.](1297-9716-44-83-5){#F5}

In contrast, TNFα, CD80 and A3Z1 and IL-10 expression did not increase upon infection with most of the strains. Remarkably, infection with Seui strain induced higher TNFα, CD80 and IL-10 expression than pN3 treated cells (Figure [5](#F5){ref-type="fig"}).

Env-mediated entry studies with pseudotyped viruses and MR involvement
----------------------------------------------------------------------

Knowing, on the one hand, the capacity of SRLV to infect MDM and trigger the production of an M2 phenotype (above) and, on the other hand, the possible role of MR in SRLV entry and infection \[[@B31]\] and the increased production of MR upon IL-4 stimulation, we first studied env-mediated viral entry using for infection, pseudoviruses expressing the envelope protein of known SRLV strains (Ev1, CAEV-Co, Roccaverano, Seui) or VSV protein G (Figure [6](#F6){ref-type="fig"}a). The results indicate that viral entry into MDM was not affected by the particular macrophage phenotype (M1 or M2) since IFN-γ and IL-4 stimulated macrophages showed similar numbers of focus forming units with the different pseudotypes.

![**Entry assay with pseudotyped viral particles.** IFN-γ, IL-4 and pN3 (control) stimulated MDM **(a)** and CHO-MR **(b)** were either treated or non-treated with mannan (1 mg/mL) before infection with pseudoviral particles bearing the envelope glycoproteins of the strains EV1 (empty boxes), CAEV-Cork (grey boxes), Roccaverano (horizontal-lined boxes), Seui (vertical-lined boxes) or the control VSV-G (full boxes). Foci of transduced cells were counted using alkaline phosphatase activity staining. Values are expressed as median focus-forming units per mL (FFC/mL) of at least 3 independent experiments.](1297-9716-44-83-6){#F6}

Viral entry was significantly inhibited by mannan treatment when using Roccaverano pseudotyped particles overall in IL-4 stimulated MDM, and the inhibitory effect was non-significant for Ev1, CAEV-Co, Seui or VSV-G pseudotyped virions. The highest entry values were reached with pantropic VSV-G pseudovirions, as expected (Figure [6](#F6){ref-type="fig"}a).

Next, we determined if the mannan blocking effects of env-mediated entry and subsequent infection could be attributed to the involvement of the MR receptor at viral entry, also using for this the pseudoviruses described above. For this we used CHO-MR cells stably expressing MR \[[@B24]\], but not other SRLV receptors, and assessed the effect of mannan treatment (Figure [6](#F6){ref-type="fig"}b). CHO-MR cells challenged with EV1, CAEV-Co, Roccaverano, Seui or VSV-G pseudotyped viruses showed a heterogeneous pattern of viral entry and suggest that mannan exposure would inhibit infections by Ev1, Roccaverano and Seui pseudotyped virions but did not hamper CAEV-Co or VSV-G entry (Figure [6](#F6){ref-type="fig"}b).

Discussion
==========

In SRLV infections, immune responses constitute a double-edge sword, since on one side they are essential against infections \[[@B37]\] and on the other side they lead to follicular hyperplasia and mononuclear cell infiltration, the main causes of tissue damage in SRLV-related lesions \[[@B11],[@B38]\]. Macrophages, the main target cells for SRLV infection, play a pivotal role in the process, disseminating the virus and providing antigen, costimulatory signals and cytokines, inducers or regulators of immune responses. In addition, macrophages suffer alterations upon lentiviral infection, but subsets of macrophages have not been identified yet in small ruminant species. Our results, strongly suggest that M1 and M2, main patterns of differentiation, are well conserved among species - including small ruminants - being induced by IFN-γ and IL-4, respectively. In small ruminants, stimulation with M1-like stimulus (IFN-γ) clearly induced an increased expression of not only TNF-α, as in humans and mice \[[@B39]\] but also APOBEC3 (A3Z1) and the costimulatory molecule CD80, together with a decreased expression of MR and DC-SIGN. Conversely, stimulation with M2 stimulus (IL-4, IL-13, IL-10) conferred an induction of not only MR but also DC-SIGN and IL-10. Interestingly, LPS and negative controls (pN3) induced an intermediate (M1-to-M2) pattern and a clear M2 pattern, respectively. LPS has been associated with an M2b profile \[[@B19]\], with high levels of proinflammatory cytokines together with high IL-10 \[[@B40],[@B41]\] as shown by our studies.

SRLV viral infection induced M2 polarization of macrophages, which also exhibited high MR and DC-SIGN expression as observed upon IL-4 stimulation. If this SRLV-mediated M2 induction occurs in vivo in alveolar macrophages of infected animals, infection would be enhanced, as these cells would show a M2 phenotype with a high expression of pattern-recognition receptors such as MR and scavenger receptors \[[@B42]\]. This pattern would favor viral spread as observed \[[@B43]\] and also in this study using M2 polarized macrophages. Ovine alveolar macrophages expressing scavenger receptor CD163, a hallmark of M2 differentiation, were found to be highly related to the presence of SRLV capsid protein in persistently infected sheep \[[@B44]\], in agreement with our results. However, during early infection in vivo, new M1 cells may infiltrate into the tissue and initially control the incoming virus. After encountering the virus (Figure [5](#F5){ref-type="fig"}) and also for physiological reasons (M1 cells last a few days; \[[@B45]\]), these M1 would eventually switch to M2 macrophages \[[@B46]\] allowing virus replication as well as infection spread since M2 cells can live from several weeks to years \[[@B47]\]. M1 cells are non-motile since inflammation is better tolerated in a restricted site, but M2 cells instead are motile (amoeboid and mesenchymal modes), able to move across a 3D matrix \[[@B48]\] favoring infection spread to other target organs. M2 cells are tolerogenic and surely are the main macrophages in SRLV infection since animals that reach the clinical stage present high levels of IgG1, IL-4 and low levels of B7 molecule transcripts that would impair antigenic presentation leading to anergic responses and T cell exhaustion. However, care should be taken when interpreting this picture since it is also plausible that M1 cells somehow impaired in their ability to restrict SRLV, could be responsible for both the tolerance and immunomediated lesions.

The Roccaverano SRLV strain showed an increased entry level into M2 macrophages compared to M1 suggesting a different receptor usage for genotype E1, whereby this genotype would enter the cell mainly via mannose recognizing receptors such as MR, whereas other strains would use additional receptors present in macrophages \[[@B31],[@B32]\]. The levels of env-related entry into CHO-MR cells found in this study in the presence/absence of mannan may also suggest that SRLV can enter M2 cells via MR.

M2, the most susceptible macrophages for SRLV infection, could allow viral proliferation and promote pathogenesis in vivo by at least two different mechanisms. One pathway would involve cellular receptors that may allow or enhance viral entry, and the other related to poor expression of B7 (CD80/86) costimulatory molecules, also observed here in M2 profiles, which would lead to the lack of T cell responses in vivo \[[@B30]\]. Arguing also in favour of these mechanisms, are studies showing that IFN-γ (leading to the M1 phenotype) selectively down regulates activity of MR \[[@B49],[@B50]\] and M1 chemokines amplify the DTH response, which is reduced in SRLV affected animals \[[@B51]\].

Interestingly, infection block (decreased RT-activity) in M1 compared to M2 MDM did not occur at the entry step, since the degree of entry was similar in M1 and M2 cells. Rather, blockage occurred at post-entry steps since preliminary qPCR data suggest that integration, evaluated as proviral load, was lower in IFN-γ than IL-4 stimulated cells (data not shown). Post-integration restriction may include the involvement of TRIM5 and APOBEC, as described in human HIV-1 infections \[[@B22]\]. M1 and M2 human macrophages showed restriction against HIV-1 infection by inducing factors like APOBEC3G or reducing the expression of certain receptors (CD4) respectively \[[@B22]\]. In this study, M1 differentiation may have restricted SRLV replication through A3Z1 induction, according to the A3Z1 mRNA levels observed. Conversely, M2 favoured virus replication likely due to differential receptor usage of SRLV compared with HIV-1.

Macrophages respond to stimuli temporarily reverting their differentiation pattern, depending on the cytokine present \[[@B52],[@B53]\]. Thus polarization is a continuous reversible M1/M2 differentiation process, as confirmed in ovine macrophages, reflecting that profiles are not static terminally-differentiated states. This plasticity may have important consequences in chronic lentiviral infections where SRLV replicates at higher levels in M2 compared to M1 macrophages. Different strategies can be proposed in order to block or at least relieve M2 differentiation and therefore viral spread, since macrophages do not necessarily suffer apoptosis or emigration after inflammation \[[@B54],[@B55]\]. These strategies have been applied against tumour diseases, where an M2 phenotype of macrophages may predominate \[[@B56]\] and the cure has involved a switch of the immune response to M1 by pharmacological treatment \[[@B57]\].

Interestingly, macrophages previously exposed to rhinoviruses show a reduced antibacterial capacity \[[@B58]\] and also SRLV infected macrophages showed a reduced phagocytic activity against bacteria indirectly facilitating secondary infections \[[@B59]\] suggesting the induction of an M2 phenotype. Mycoplasma co-infection malp (macrophage activation lipoprotein) may modify proteins presented on the plasmatic membrane that could act as SRLV (co)-receptors and favour infection \[[@B60]\]. Essentially, data regarding macrophage differentiation and characterization of the respective profiles share several features with the well depicted picture in humans and mice strongly suggesting a widely conserved maturation pathway, further reinforcing the M1/M2 model and validating their use.
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